Navigation Links
A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing
Date:5/16/2013

censing of clinical stage therapeutics. D3 builds on Singapore's existing drug discovery capabilities and strengthens the local biomedical innovation landscape. It was founded to be a cost-effective and professional development partner able to advance and add value to early-stage projects on a 'shared-risk, shared-reward' basis. D3's primary focus is on developing drugs targeted at oncology indications and infectious diseases but the door is open to other indications if a partner brings the necessary disease knowledge. D3 is jointly funded by A*STAR, the Ministry of Health's National Medical Research Council and the National Research Foundation.For more information about D3, please visit http://www.d3.a-star.edu.sg

About Cytos Biotechnology Ltd

Cytos is a public biopharmaceutical company focused on the development of targeted immuno-therapies. The Company's lead product candidate CYT003 is a first-in-class immune modulatorin Phase 2 clinical development as a potential new treatment for allergic asthma.

CYT003 acts via a novel, allergen-independent mechanism of action to selectively suppress the body's immune response to allergens, a predominant risk factor for asthma. In a successfully completed Phase 2a study, CYT003 was shown to maintain asthma control and lung function in patients with persistent allergic asthma, even as standard inhaled corticosteroid treatment was withdrawn. CYT003 has been shown to be safe in over 450 patients to date.

Cytos was founded in 1995 as a spinoff from the Swiss Federal Institute of Technology (ETH) in Zurich. It is located in Schlieren (Zurich), Switzerland. The Company is listed according to the Main Standard on the SIX Swiss Exchange Ltd under the symbol CYTN
'/>"/>

SOURCE Cytos Biotechnology Ltd
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Tornado Medical Systems And A*STARs Institute Of Microelectronics Partner To Commercialise Nanospectrometers For Optical Coherence Tomography Applications
2. GlaxoSmithKline and A*STARs Institute of Chemical Engineering and Sciences to Develop new Medicines for Emerging Markets
3. Cytos Biotechnology Ltd Reports Third Quarter 2012 Financial Results, Recent Development and Outlook
4. CytoSorbents Receives Approximately $400,000 in Non-Dilutive Capital from the Sale of Net Operating Loss Carryovers
5. Cytos VLP Platform is Basis for Phase 1 Clinical Trial with Anti-IgE Vaccine
6. Industry Veteran Brings Sales Expertise to AlloSources Growing Distribution Network
7. Cardinal Health Brings Resolution to Litigation with DEA Settlement
8. CASiGEN Pharma Receives A World-wide Exclusive License From GIBH To Bring New Potential Diabetes Treatments To The Global Market
9. Clinical Site Services Is Bringing 3x More Patient Enrollment to the 48th Annual DIA Meeting
10. Vocollect Healthcare Systems And Prime Care Technologies Bring AccuNurse Key Performance Metrics To Long-Term Care Providers Via primeVIEW Digital Dashboard
11. Health Diagnostic Laboratory, Inc. (HDL, Inc.) Brings Advanced Testing to Capitol Hill, Discusses Health Care Cost Savings and Quality Improvement Potential
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... 26, 2015  AbbVie (NYSE: ABBV ... in its neuroscience and oncology development programs have ... American Academy of Neurology annual meeting in ... 18-25. The accepted abstracts feature results from studies ... investigational treatments in AbbVie,s pipeline. Presentations will include ...
(Date:2/26/2015)... Feb. 26, 2015  Mobility Ventures LLC, an AM ... Bank of America (NYSE: BAC ) that ... financing of the revolutionary MV-1 - - the world,s ... ground up to provide safe and comfortable transportation for ... their loan to purchase a new MV-1 vehicle at ...
(Date:2/26/2015)... -- Every year many millions of donations are obtained ... year after year doctors and the medical profession continue ... to determine the status of heart health in all ... though that technology is over 100 years old, ... (while most patients do not know) that EKG,s, in ...
Breaking Medicine Technology:AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 2AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 3AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 4AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 5AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 6AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 7Mobility Ventures and Bank of America Announce New Agreement to Simplify Retail Consumer Financing for MV-1 Universally Accessible Vehicle 2Mobility Ventures and Bank of America Announce New Agreement to Simplify Retail Consumer Financing for MV-1 Universally Accessible Vehicle 3National Heart Health Month In February 2
... LLC announced today that it has achieved the ... Products Certification for Health Information Line. The accreditation ... nurseline staffed by highly experienced, registered nurses that ... providing immediate clinical support for everyday health issues ...
... England, April 6, 2011 BioWa, Inc. (BioWa) ... they have entered into a license agreement to ... Technology platform for the development of antibody dependent ... OBT intends to use POTELLIGENT® Technology to develop, ...
Cached Medicine Technology:Alere Earns NCQA Health Information Products Certification for Health Information Line 2Oxford BioTherapeutics Licenses BioWa's POTELLIGENT® Technology for the Research and Development of its Therapeutic Antibodies in Cancer 2Oxford BioTherapeutics Licenses BioWa's POTELLIGENT® Technology for the Research and Development of its Therapeutic Antibodies in Cancer 3
(Date:2/27/2015)... February 27, 2015 “ Logical Operations ... monthly Tech Report, which takes a look at the ... consumers. Mallory Sofastaii, a special reporter for NewsWatch and ... viewers how this company helps companies avoid cyber security ... news, they’ll probably see cyber security somewhere in the ...
(Date:2/27/2015)... 27, 2015 Mirena IUD lawsuits ( ... allegedly suffered uterine perforations and other serious harm due ... to move forward in the multicounty litigation underway in ... reports. Court records indicate that the proceeding’s 34th ... a Conference convened that same day. (In Re: Mirena ...
(Date:2/27/2015)... February 27, 2015 Jupiter Medical Center ... partnership, Mount Sinai Heart New York at Jupiter Medical ... in South Florida. , “This innovative collaboration with ... we’re delivering unparalleled health care in our very own ... Officer of Jupiter Medical Center. “This kind of innovative ...
(Date:2/27/2015)... Lyophilization has important applications in the pharmaceutical and biotechnology ... stabilize, store and increase the shelf life of drug ... antibodies, proteins, enzymes, hormones, blood plasma and bacteria-derived compounds ... market was valued at $1,969.7 million in 2014 and ... at a CAGR of 6.2% during the forecast period. ...
(Date:2/27/2015)... DiabetesSisters, a national 501c3 nonprofit ... by women with diabetes, is proud to announce ... aims to develop the skills of 24 carefully ... weekend of April 24-26th in Raleigh, NC. ... participants was made based on the applicant’s demonstrated ...
Breaking Medicine News(10 mins):Health News:A Way for Companies to Avoid Cyber Security Threats was Featured on NewsWatch Television on January 30, 2015 2Health News:Mirena Lawsuits Progress in New Jersey with Issuance of New Case Management Order, Bernstein Liebhard LLP Reports 2Health News:Mirena Lawsuits Progress in New Jersey with Issuance of New Case Management Order, Bernstein Liebhard LLP Reports 3Health News:Jupiter Medical Center and Mount Sinai Heart New York Announce Landmark Partnership 2Health News:Jupiter Medical Center and Mount Sinai Heart New York Announce Landmark Partnership 3Health News:Jupiter Medical Center and Mount Sinai Heart New York Announce Landmark Partnership 4Health News:Jupiter Medical Center and Mount Sinai Heart New York Announce Landmark Partnership 5Health News:Lyophilization Equipment Market worth $2,655.9 Million by 2019 - New Research Report by MarketsandMarkets 2Health News:Lyophilization Equipment Market worth $2,655.9 Million by 2019 - New Research Report by MarketsandMarkets 3Health News:DiabetesSisters Announces 2015 Leadership Institute for April 24-26, 2015 2
... respiratory trouble, researchers note , THURSDAY, Oct. 4 ... at Children,s Hospital Boston have found new information ... (BPD), a lung disease that affects premature newborns ... prevent or treat BPD, which can cause long-term ...
... BETHESDA, Md., Oct. 4 New research from ... colonography,published in the New England Journal of Medicine ... colorectal cancer screening using a,CT scan of the ... and to advancing new frontiers in medicine.,While all ...
... for Geriatric Nursing Excellence in the University of Iowa ... the nation, have been funded for a four-year $1.2 ... recent evidence-based guidelines for caring for elders with mental ... Nursing Excellence, which will form the Geropsychiatric Nursing Collaborative, ...
... BENSALEM, Pa., Oct. 4 Law Offices of Howard ... been filed on behalf,of shareholders who purchased the common ... MEND ) between February 12,2007 and September 17, 2007, ... in the United States District Court for the,Southern District ...
... potentially fatal tick-borne illness has nearly tripled, research shows , ... Mountain spotted fever in the United States almost tripled from ... The potentially fatal disease is caused by Rickettsia rickettsii ... of the dog tick or Rocky Mountain wood tick. Within ...
... YORK, October 4, 2007 The Board of,Directors of ... dividends of $.36 per common share, payable on November ... The Company has paid,uninterrupted dividends on its common stock ... Colgate-Palmolive is a leading global consumer,products company, tightly focused ...
Cached Medicine News:Health News:Genes Give Clues to Newborn Lung Disease 2Health News:Despite Advances in the Accuracy of CT Colonography in Detecting Polyps, Digestive Health Experts Urge Patients to Consider Risks and Realities 2Health News:Despite Advances in the Accuracy of CT Colonography in Detecting Polyps, Digestive Health Experts Urge Patients to Consider Risks and Realities 3Health News:Despite Advances in the Accuracy of CT Colonography in Detecting Polyps, Digestive Health Experts Urge Patients to Consider Risks and Realities 4Health News:Surge in U.S. Cases of Rocky Mountain Spotted Fever 2
LifeStent FlexStar delivery systems offer clinicians multiple methods for stent deployment to accommodate individual preference....
... Tendril ST leads ... pacing leads, designed to ... reliability and flexibility to ... These pre-formed "J leads ...
RV Tracking for 100 % Resynchronization...
O-arm combines the best features of a traditional c-arm with an intra-operative 3D scannerfor unparalleled surgical imaging....
Medicine Products: